Financial reports
NT 10-K
Notice of late annual filing
31 Mar 17
10-Q
2016 Q3
Quarterly report
16 Nov 16
NT 10-Q
Notice of late quarterly filing
14 Nov 16
10-Q
2016 Q2
Quarterly report
12 Aug 16
10-Q
2016 Q1
Quarterly report
20 May 16
NT 10-Q
Notice of late quarterly filing
16 May 16
10-K
2015 FY
Annual report
30 Mar 16
10-Q
2015 Q3
Quarterly report
16 Nov 15
10-Q
2015 Q2
Quarterly report
14 Aug 15
10-Q
2015 Q1
Quarterly report
15 May 15
Current reports
8-K
Other Events
21 Apr 17
8-K
Departure of Directors or Certain Officers
22 Mar 17
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
2 Feb 17
8-K
Echo Therapeutics Announces Dismissal of Federal Court Action
27 Dec 16
8-K
Echo Therapeutics Announces Federal Court’s Denial of Preliminary Injunction and Lifting of Temporary Restraining Order
14 Dec 16
8-K
Other Events
2 Dec 16
8-K
Changes in Registrant's Certifying Accountant
1 Dec 16
8-K
Entry into a Material Definitive Agreement
23 Nov 16
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
19 Oct 16
8-K
Departure of Directors or Certain Officers
27 Sep 16
Registration and prospectus
25-NSE
Exchange delisting
26 Sep 16
S-3
Shelf registration
10 Jun 16
S-8
Registration of securities for employees
13 May 16
424B3
Prospectus supplement
6 May 16
S-3
Shelf registration
14 Apr 16
D
$6M in debt / options / securities to be acquired, sold $1.79M, 15 investors
8 Feb 16
D
$10M in equity / options / securities to be acquired, sold $10M, 4 investors
19 Dec 13
RW
Registration withdrawal request
17 Dec 13
S-1
IPO registration
2 Dec 13
424B5
Prospectus supplement for primary offering
14 Jun 13
Proxies
DEFA14A
Additional proxy soliciting materials
13 Apr 16
DEF 14A
Definitive proxy
12 Apr 16
DEFA14A
Additional proxy soliciting materials
14 Mar 16
DEFA14A
Additional proxy soliciting materials
4 Mar 16
DEF 14A
Definitive proxy
4 Mar 16
PRE 14A
Preliminary proxy
23 Feb 16
PRRN14A
Revised preliminary proxy statement filed by non-management
20 Oct 14
PRER14A
Preliminary revised proxy
16 Oct 14
PRRN14A
Revised preliminary proxy statement filed by non-management
14 Oct 14
DFAN14A
Additional proxy materials by non-management
6 Oct 14
Other
REVOKED
Registration or securities revoked
7 Sep 21
EFFECT
Notice of effectiveness
24 Jun 16
UPLOAD
Letter from SEC
23 Jun 16
CORRESP
Correspondence with SEC
23 Jun 16
EFFECT
Notice of effectiveness
29 Apr 16
UPLOAD
Letter from SEC
26 Apr 16
CORRESP
Correspondence with SEC
26 Apr 16
UPLOAD
Letter from SEC
11 Jun 15
UPLOAD
Letter from SEC
24 Oct 14
UPLOAD
Letter from SEC
17 Oct 14
Ownership
SC 13D
Echo Therapeutics, Inc.
6 Apr 17
4
SHEPARD M GOLDBERG
23 Mar 17
4
MICHAEL M GOLDBERG
23 Mar 17
4
ALAN WAYNE SCHOENBART
22 Mar 17
4
ALAN WAYNE SCHOENBART
22 Mar 17
4/A
ALAN WAYNE SCHOENBART
23 Nov 16
4/A
SHEPARD M GOLDBERG
22 Mar 16
4/A
MICHAEL M GOLDBERG
22 Mar 16
4/A
Elazer R Edelman
22 Mar 16
4
Elazer R Edelman
3 Mar 16